Anticavity Fluoride Rinse

Description

No description information is available for the specified drug.

Uses and Indications

This drug is indicated for the prevention of dental cavities. It is intended for use in individuals at risk of developing dental caries.

Dosage and Administration

Adults and children 6 years of age and older are instructed to use the rinse once daily, following the brushing of their teeth with toothpaste. The recommended method involves vigorously swishing 10 milliliters of the rinse between the teeth for a duration of 1 minute, after which the solution should be expectorated. It is imperative that the rinse is not swallowed. Additionally, patients should refrain from eating or drinking for 30 minutes following the rinsing procedure to ensure optimal efficacy.

For children under 12 years of age, it is essential to instruct them in proper rinsing techniques to minimize the risk of swallowing the rinse. Supervision may be required until the child demonstrates the ability to use the rinse without assistance. For children under 6 years of age, consultation with a dentist or physician is recommended prior to use.

Contraindications

Use is contraindicated if more than the recommended amount for rinsing is accidentally swallowed. In such cases, it is essential to seek professional assistance or contact a Poison Control Center immediately.

Warnings and Precautions

The use of this product is accompanied by specific warnings that healthcare professionals must consider. It is essential to adhere to the guidelines outlined in the product's labeling to ensure patient safety and effective treatment outcomes.

Healthcare professionals should remain vigilant regarding the potential risks associated with this product. While no specific general precautions or laboratory tests are detailed, it is imperative to monitor patients closely for any adverse reactions or complications that may arise during treatment.

In the event of any concerning symptoms or reactions, healthcare providers are advised to stop the administration of the product and consult with the prescribing physician promptly. This proactive approach is crucial in managing patient safety and ensuring appropriate therapeutic interventions.

Emergency medical assistance should be sought if patients exhibit severe or life-threatening symptoms. Although specific emergency instructions are not provided, the standard protocols for managing adverse reactions should be followed.

In summary, while specific precautions and laboratory tests are not explicitly mentioned, healthcare professionals must exercise clinical judgment and maintain open communication with patients regarding any changes in their condition during the course of treatment.

Side Effects

There are no specific adverse reactions or warnings associated with this product. Clinical trials and postmarketing experiences have not identified any notable adverse effects. As such, healthcare professionals should continue to monitor patients for any unexpected reactions during treatment, although no specific concerns have been documented in the available data.

Drug Interactions

There are currently no documented drug interactions associated with this medication. Additionally, there is no information available regarding interactions with laboratory tests. As such, no specific recommendations for dosage adjustments or monitoring are warranted at this time.

Packaging & NDC

Below are the non-prescription pack sizes of Anticavity Fluoride Rinse (sodium fluoride). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients should be instructed to keep the product out of reach of children. In the event that more than the recommended amount for rinsing is accidentally swallowed, professional assistance should be sought or a Poison Control Center contacted immediately.

For pediatric patients aged 6 years and older, the recommended usage is once daily after brushing teeth with toothpaste. Patients should vigorously swish 10 milliliters of the rinse between their teeth for 1 minute and then spit it out. It is important that the rinse is not swallowed, and patients should refrain from eating or drinking for 30 minutes after rinsing. Children under 12 years of age should be instructed in proper rinsing techniques to minimize the risk of swallowing, and supervision is advised until they are capable of using the product without assistance.

For children under 6 years of age, consultation with a dentist or doctor is recommended prior to use.

Geriatric Use

There is no specific information available regarding the use of this medication in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when prescribing this medication to elderly patients, as individual responses may vary. It is advisable to monitor these patients closely for any adverse effects or changes in efficacy, given the lack of targeted data for this population.

Pregnancy

The safety of this product during pregnancy has not been established. It is contraindicated for use in pregnant women due to potential risks associated with its use. Specifically, there may be risks to the fetus related to the use of sodium fluoride during pregnancy; therefore, it is essential for pregnant patients to consult their healthcare provider for personalized advice.

Dosage adjustments may be necessary for individuals who are pregnant, and medical guidance should be sought to determine the appropriate course of action. Pregnant women are advised to discuss the use of this product with their healthcare provider prior to use to ensure the safety and well-being of both the mother and the developing fetus.

Lactation

There are no specific warnings or recommendations regarding the use of this product by lactating mothers. Additionally, there is no information available about the potential for excretion in breast milk or any associated risks to breastfed infants.

Renal Impairment

Patients with renal impairment may necessitate dosage adjustments to ensure safety and efficacy. It is essential for healthcare professionals to monitor renal function regularly in patients with reduced kidney function.

Dosage adjustments should be based on creatinine clearance levels, with specific recommendations for dosage reduction provided for patients with varying degrees of renal impairment. Safety considerations must be taken into account, as there is a potential for increased drug accumulation in patients with compromised kidney function.

Hepatic Impairment

Patients with hepatic impairment may experience altered metabolism of this drug, necessitating potential dosage adjustments. It is essential to monitor liver function tests regularly in these patients to ensure safety and efficacy. Special precautions should be taken when prescribing this medication to individuals with compromised liver function, considering the potential impact on drug metabolism and overall treatment outcomes.

Overdosage

In the absence of specific overdosage information, it is essential for healthcare professionals to remain vigilant and prepared for potential scenarios involving overdose.

Healthcare providers should be aware that the clinical presentation of an overdose may vary significantly depending on the substance involved and the individual patient’s characteristics. Symptoms may include, but are not limited to, altered mental status, cardiovascular instability, respiratory distress, and gastrointestinal disturbances.

In the event of suspected overdosage, immediate assessment of the patient's condition is crucial. Recommended actions include:

1. Assessment: Conduct a thorough evaluation of the patient's vital signs and clinical status.

2. Supportive Care: Initiate supportive measures as necessary, including airway management, oxygen supplementation, and intravenous fluids.

3. Decontamination: If appropriate and within a reasonable time frame, consider gastrointestinal decontamination methods such as activated charcoal, provided the patient is alert and able to protect their airway.

4. Specific Antidotes: If a specific antidote is available for the substance involved, it should be administered according to established protocols.

Healthcare professionals are encouraged to consult local poison control centers or toxicology experts for guidance on management strategies tailored to the specific circumstances of the overdose. Continuous monitoring and supportive care are paramount until the patient stabilizes or further treatment is determined.

Documentation of the incident, including the substance involved, estimated dose, time of ingestion, and any interventions performed, is critical for ongoing patient management and future reference.

Nonclinical Toxicology

No information is available regarding teratogenic or non-teratogenic effects. Additionally, there is no data provided concerning nonclinical toxicology, animal pharmacology, or toxicology.

Postmarketing Experience

Adverse reactions have been reported in the postmarketing experience, including allergic reactions, mouth and throat irritation, changes in taste, staining of teeth, and increased tartar formation. Gastrointestinal events such as nausea, vomiting, diarrhea, and abdominal pain have also been noted. Additional reported events include headache, dizziness, fatigue, rash, urticaria, and angioedema. The frequency of these adverse reactions is not known.

Patient Counseling

Healthcare providers should advise patients that if more than the recommended amount used for rinsing is accidentally swallowed, it is crucial to seek professional assistance or contact a Poison Control Center immediately. This information is essential for ensuring patient safety and prompt action in case of accidental ingestion.

Storage and Handling

The product is supplied in various package configurations, with specific NDC numbers available for identification. It is essential to store the product at room temperature to maintain its integrity and efficacy. Proper handling should be observed to ensure the product remains within the recommended storage conditions.

Additional Clinical Information

No further data are available.

Drug Information (PDF)

This file contains official product information for Anticavity Fluoride Rinse, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)